14-day Premium Trial Subscription Try For FreeTry Free
$1.11
+0.0300 (+2.78%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.540 $1.15 Thursday, 2nd May 2024 MCRB stock ended at $1.11. This is 2.78% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.21% from a day low at $1.01 to a day high of $1.11.
90 days $0.540 $1.24
52 weeks $0.540 $6.26

Historical Seres Therapeutics prices

Date Open High Low Close Volume
May 02, 2024 $1.07 $1.11 $1.01 $1.11 3 207 935
May 01, 2024 $1.02 $1.15 $1.00 $1.08 6 786 137
Apr 30, 2024 $0.91 $1.00 $0.84 $0.99 9 993 532
Apr 29, 2024 $0.86 $0.92 $0.83 $0.91 7 401 217
Apr 26, 2024 $0.741 $0.83 $0.740 $0.83 3 864 172
Apr 25, 2024 $0.713 $0.83 $0.700 $0.743 3 430 898
Apr 24, 2024 $0.750 $0.786 $0.696 $0.730 5 803 543
Apr 23, 2024 $0.639 $0.80 $0.630 $0.760 11 816 243
Apr 22, 2024 $0.600 $0.635 $0.581 $0.625 4 178 750
Apr 19, 2024 $0.580 $0.606 $0.540 $0.560 3 654 500
Apr 18, 2024 $0.627 $0.630 $0.581 $0.584 3 708 151
Apr 17, 2024 $0.653 $0.655 $0.602 $0.627 4 814 301
Apr 16, 2024 $0.616 $0.660 $0.607 $0.636 4 155 569
Apr 15, 2024 $0.640 $0.654 $0.611 $0.618 3 806 188
Apr 12, 2024 $0.700 $0.701 $0.631 $0.655 4 119 867
Apr 11, 2024 $0.695 $0.700 $0.661 $0.682 4 643 363
Apr 10, 2024 $0.695 $0.698 $0.660 $0.689 4 948 018
Apr 09, 2024 $0.720 $0.748 $0.687 $0.709 4 894 595
Apr 08, 2024 $0.751 $0.754 $0.725 $0.732 2 559 045
Apr 05, 2024 $0.770 $0.780 $0.732 $0.763 3 311 405
Apr 04, 2024 $0.733 $0.791 $0.715 $0.755 4 291 068
Apr 03, 2024 $0.761 $0.770 $0.710 $0.726 6 048 532
Apr 02, 2024 $0.779 $0.779 $0.750 $0.763 1 988 271
Apr 01, 2024 $0.780 $0.799 $0.752 $0.767 3 235 158
Mar 28, 2024 $0.787 $0.798 $0.762 $0.774 3 013 854
Click to get the best stock tips daily for free!

About Seres Therapeutics

Seres Therapeutics Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri... MCRB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT